The lifetime risk of breast cancer and ovarian cancer with BRCA1 mutation is approximately 60% (95% CI: 44–75%) and 59% (95% CI: 43–76%), respectively [22]. This evidence concerns the gene BRCA1 and ovarian carcinoma.